Novartis welcomes the listing of first-in-class cholesterol-lowering therapy

Matt Zeller, country president of Novartis Australia and New Zealand, said, “The impact of CVD in Australia is devastating, claiming one life every 12 minutes. Now, Leqvio is available on the PBS and this first-in-class treatment option has the potential to transform patient care and help improve the lives of individuals living with CVD.” …